Orasis Pharmaceuticals
PrivateLast Round
Debt
Oct 8, 2024
Total Funding Raised
$121M
Momentum Score
25 /100
Company Overview
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company focused on developing corrective eye drops that enhance near-uncorrected visual acuity and alleviate presbyopia symptoms, providing patients with a non-invasive alternative to reading glasses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orasis Pharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Orasis Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 8, 2024 | ||||
| Series D | Oct 8, 2024 | ||||
| Series C | Sep 10, 2020 | ||||
| Series B | Jun 5, 2018 |
Key People
Founding team and executive leadership
Orasis Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeSci Venture Partners | Series C, Series B |
| Arboretum Ventures | Series D |
| Maverick Ventures | Series C, Series D |
| Maverick Ventures Israel | Series C |
| SBI JI | Series D, Series B, Series C |
| Catalio Capital Management | Debt, Series D |
| Sequoia Capital | Series C, Series D, Series B |
Orasis Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orasis Pharmaceuticals's valuation, stock price, and market status.
